| Gene symbol | E7 | Synonyms | None | Type of gene | protein-coding |
| Chromosome | - | Map location | NC_001526.4 (7604..7900) | dbXrefs | |
| Description | transforming protein E7 | ||||
| GTO ID | GTC3382 |
| Trial ID | NCT05787535 |
| Disease | Cervical Cancer | Vulva Carcinoma | Penis Carcinoma | Anal Carcinoma | Head and Neck Squamous Cell Carcinoma | Vagina Tumor |
| Altered gene | E7 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HRYZ-T101 TCR-T cells |
| HLA | HLA-DRB1*09:01 |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | A Phase I Study to Evaluate the Safety, Tolerance and Efficacy of HRYZ-T101 TCR-T Cell for HPV18 Positive Advanced Solid Tumor |
| Year | 2023 |
| Country | China |
| Company sponsor | SYZ Cell Therapy Co.. |
| Other ID(s) | HRYZ-T101-1002 |
| Cohort 1 | |||||||
|
|||||||